Douglas Saltel

Title: Douglas Saltel - Pioneer in Alcohol-Resistant Pharmaceutical Compositions

Introduction

Douglas Saltel is an innovative inventor based in Austin, TX, who has made significant contributions to the field of pharmaceuticals. With a keen focus on enhancing drug formulations, Saltel holds one patent that showcases his expertise and dedication to improving patient outcomes.

Latest Patents

Saltel's notable patent is titled "Alcohol-resistant oral pharmaceutical compositions of lorazepam." This invention describes oral pharmaceutical compositions and dosage forms designed to exhibit reduced drug release in the presence of alcohol. The formulation consists of a controlled release substrate of lorazepam, encased in an alcohol-resistant coating, providing a critical advancement in safeguarding the efficacy of the medication.

Career Highlights

Currently, Douglas Saltel is employed at Edgemont Pharmaceuticals, LLC, where he plays a vital role in the research and development of pharmaceutical innovations. His work reflects a commitment to creating safer and more effective medications for patients, particularly in relation to the use of lorazepam.

Collaborations

In his professional endeavors, Saltel collaborates closely with Michael Vachon, a colleague at Edgemont Pharmaceuticals. Their joint efforts are focused on refining pharmaceutical compositions to meet the complex needs of users, particularly concerning medication interactions with alcohol.

Conclusion

Douglas Saltel's contributions to pharmaceutical sciences demonstrate the importance of innovation in developing safe and effective medications. With his patent on alcohol-resistant lorazepam formulations, he continues to pave the way for advancements in patient care and medication safety in the healthcare industry.